Overview

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of Combivir plus abacavir plus 141W94 in patients who previously have used anti-HIV drugs.
Phase:
N/A
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir
Amprenavir
Lamivudine
Lamivudine, zidovudine drug combination
Zidovudine